Ben Kong, PharmD, BCPS, shares a perspective on a study of biomarkers published recently in ONCOLOGY.
Ben Kong, PharmD, BCPS
Advertisement
Articles by Ben Kong, PharmD, BCPS
Advertisement
Latest Updated Articles
The Complexities and Art of Interpreting Biomarkers and Response to Immune Checkpoint InhibitorsPublished: May 20th 2023 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC
2
H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice
3
3 Things You Should Know About Frontline TROP2-Targeting Antibody-Drug Conjugate/Immune Checkpoint Inhibitor Combinations to Treat Advanced Triple-Negative Breast Cancer
4
Novel Intratumoral Formulation Shows Responses/Safety in Metastatic Cancers
5
